Physician profile
Joan Dolinak
NPI 1750571949
$8,246.97
in general payments reported to CMS, 2019-2025
5 companies · $7,568 in 2025
The $7,568 reported for 2025 was more than what 93% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.61 · 2023: $557 · 2024: $97.79 · 2025: $7,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,050 · Food and Beverage: $1,350 · Travel and Lodging: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,050.00 |
| Food and Beverage | $1,349.66 |
| Travel and Lodging | $823.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,366.90 | 2022-2025 | Versajet, Acticoat 4" X 4", Oasis |
| Avita Medical Americas, LLC | $621.68 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Integra Lifesciences Corporation | $151.11 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $97.79 | 2024 | Novosorb Btm |
| Polymedics Innovations INC. | $9.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Dolinak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.